Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$8,303,654
+$1,926,889 QoQ
Shares Held
6,923
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#1,360
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First Nebraska Trust Co holds $45,421,134 across 9 Drug Manufacturers - General names. LLY ranks #3 (18.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
67,346 | $17,103,863 | |
| 2 | MRK |
Merck & Co., Inc.
|
104,140 | $13,381,990 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
6,923 | $8,303,654 | |
| 4 | PFE |
Pfizer Inc
|
106,986 | $2,576,222 | |
| 5 | ABBV |
AbbVie Inc.
|
7,172 | $1,804,762 | |
| 6 | AMGN |
Amgen Inc
|
2,369 | $857,862 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
10,907 | $628,461 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,802 | $480,344 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,303,654 | 6,923 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $6,376,765 | 6,933 | Shares | Sole | 2026-06-01 | |
| 2025-12-31 | $7,397,023 | 6,883 | Shares | Sole | 2026-06-02 | |
| 2025-09-30 | $5,263,937 | 6,899 | Shares | Sole | 2026-06-09 | |
| 2025-06-30 | $5,370,182 | 6,889 | Shares | Sole | 2026-06-10 | |
| 2025-03-31 | $5,804,495 | 7,028 | Shares | Sole | 2026-06-10 | |
| 2024-12-31 | $5,576,156 | 7,223 | Shares | Sole | 2026-06-12 | |
| 2024-09-30 | $6,212,211 | 7,012 | Shares | Sole | 2026-06-12 | |
| 2024-06-30 | $6,432,724 | 7,105 | Shares | Sole | 2026-06-15 | |
| 2024-03-31 | $5,572,527 | 7,163 | Shares | Sole | 2026-06-16 | |
| 2023-12-31 | $4,283,879 | 7,349 | Shares | Sole | 2026-06-16 | |
| 2023-09-30 | $4,077,353 | 7,591 | Shares | Sole | 2026-06-16 | |
| 2023-06-30 | $3,563,779 | 7,599 | Shares | Sole | 2026-06-17 | |
| 2023-03-31 | $2,656,697 | 7,736 | Shares | Sole | 2026-06-17 | |
| 2022-12-31 | $5,624,790 | 15,375 | Shares | Sole | 2026-06-22 | |
| 2022-09-30 | $5,058,487 | 15,644 | Shares | Sole | 2026-06-22 | |
| 2022-06-30 | $9,250,930 | 28,532 | Shares | Sole | 2026-06-23 | |
| 2022-03-31 | $8,264,351 | 28,859 | Shares | Sole | 2026-06-23 | |
| 2021-12-31 | $8,029,439 | 29,069 | Shares | Sole | 2026-06-24 | |
| 2021-09-30 | $6,879,282 | 29,774 | Shares | Sole | 2026-06-25 | |
| 2021-06-30 | $6,877,337 | 29,964 | Shares | Sole | 2026-06-26 | |
| 2021-03-31 | $5,639,908 | 30,189 | Shares | Sole | 2026-06-26 | |
| 2020-12-31 | $5,074,823 | 30,057 | Shares | Sole | 2026-06-29 | |
| 2020-09-30 | $4,443,116 | 30,017 | Shares | Sole | 2026-06-29 | |
| 2020-06-30 | $5,200,565 | 31,676 | Shares | Sole | 2026-07-01 | |
| 2020-03-31 | $4,472,055 | 32,238 | Shares | Sole | 2026-07-01 | |
| No filing history on record for this holder in this stock. | ||||||